The treatment of breast cancer MCF-7 cell line with leptin leads to a remarkable increase in the expression of EMT markers (including vimentin and Snail) along with a downregulation of the epithelial marker E-cadherin (62). The gene discussed is VIM; the disease is breast carcinoma.